Related Experiment Video
Updated: Dec 8, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
HCV eradication in veterans with underlying mental health disorders and substance use
Insights
Hepatitis C treatment with direct-acting antivirals (DAAs) achieves high sustained virologic response (SVR) rates. These high SVR rates were observed in patients with mental health disorders or substance use, similar to those without these conditions.
Area of Science:
- Hepatology
- Infectious Diseases
- Psychiatry
Background:
- Hepatitis C virus (HCV) disproportionately impacts individuals with mental health disorders and substance use.
- Opioid epidemic drives increasing HCV transmission in the US.
- Limited historical access to HCV treatment for patients with mental health and/or substance use disorders.
Purpose of the Study:
- Compare sustained virologic response (SVR) rates of direct-acting antiviral (DAA) therapy for Hepatitis C virus (HCV).
- Evaluate treatment outcomes between patients with and without mental health disorders, substance use, or a combination of both.
Main Methods:
- Retrospective chart review of 833 patients completing DAA treatment at a Veterans Affairs medical center (August 2013 - August 2017).
- Patients categorized into two groups: those with mental health/substance use disorders and those without.
- Collected data on baseline variables, DAA regimen, patient engagement efforts, and SVR rates.
Main Results:
- 579 out of 833 patients had at least one mental health disorder, substance use, or both.
- Most prevalent conditions included substance use (n=333), substance-related disorders (n=176), and depressive disorders (n=159).
- No statistically significant difference in SVR rates or patient engagement efforts between groups.
Conclusions:
- Direct-acting antiviral (DAA) therapy demonstrates high efficacy for Hepatitis C virus (HCV) treatment.
- Sustained virologic response (SVR) rates exceeded 95% across the entire cohort.
- DAA treatment is effective in patients with or without mental health disorders or substance use.
Objective:
Hepatitis C virus (HCV) disproportionately affects those with mental health disorders and those with substance use, and the increasing HCV transmission in the United States is driven by the opioid epidemic. However, patients with a mental health disorder, substance use, or combination of both historically have had limited access to HCV treatment. The goal of our study was to compare sustained virologic response (SVR) rates of HCV treatment with direct-acting antivirals (DAAs) between subjects with and without a mental health disorder, substance use, or combination of both.
Methods:
We performed a retrospective chart review at 1 Veterans affairs medical center of patients enrolled in the hepatitis C pharmacy clinic who completed DAA treatment from August 17, 2013 to August 17, 2017. The participants (N = 833 patients) were categorized into 2 groups: those with at least 1 mental health disorder, substance use, or combination of both and those without. Baseline variables relevant to HCV treatment, DAA regimen, number of documented efforts to engage patients, and SVR data were collected.
Results:
Of the 833 study participants, 579 patients had a mental health disorder, substance use, or combination of both. The 3 most prevalent disorders were patient-reported substance use (n = 333), substance-related and addictive disorders (n = 176), and depressive disorders (n = 159). The SVR rates and number of documented efforts to engage patients before and during treatment through SVR laboratory completion between those with a mental health disorder, substance use, or combination of both and those without were not statically significant.
Conclusion:
DAA-based HCV treatment is highly effective with SVR rates exceeding 95% in the entire study cohort, including patients with or without mental health disorders, substance use, or combination of both.
Related Concept Videos
Retrovirus Life Cycles
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Psychosis: Goals of Pharmacotherapy
Healthcare Agencies II
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...

